Financial Performance - The company's operating revenue for Q3 2025 was ¥146,604,936.43, representing a year-on-year increase of 34.97%[3] - The total profit for the quarter was ¥22,662,651.04, showing a decrease of 17.94% compared to the same period last year[3] - Net profit attributable to shareholders was ¥23,218,225.61, down 5.98% year-on-year[3] - Total operating revenue for the first three quarters of 2025 reached ¥385,845,103.24, a 31.2% increase from ¥294,041,286.40 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was ¥56,586,865.80, compared to ¥54,627,824.73 in 2024, reflecting a 3.6% increase[19] Assets and Liabilities - The total assets at the end of the reporting period reached ¥1,788,934,867.36, an increase of 19.89% from the end of the previous year[4] - Total liabilities amounted to ¥886,448,664.01, slightly up from ¥886,139,338.63 in 2024, indicating stable financial leverage[16] - The total assets of the company as of the end of the reporting period were ¥1,788,934,867.36, compared to ¥1,492,105,289.02 in the previous year, marking a growth of 19.9%[16] Shareholder Information - The company reported a total of 9,036 common shareholders at the end of the reporting period[10] - The largest shareholder, Li Xiaomin, holds 39.41% of the shares, totaling 158,937,232 shares[10] - The second-largest shareholder, Ningbo Fengnian Rongtong Investment Management, holds 6.22% with 25,071,347 shares[10] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥155,814,159.05, reflecting a slight increase of 0.33%[3] - The cash flow from operating activities for the first three quarters of 2025 was ¥375,254,916.37, compared to ¥296,966,975.33 in 2024, showing a strong cash generation capability[22] - Operating cash inflow totaled $404,639,874.82, an increase from $342,667,241.77 in the previous period, reflecting a growth of approximately 18.1%[23] Research and Development - Research and development expenses totaled ¥14,064,097.85, accounting for 9.59% of operating revenue, a decrease of 0.62 percentage points[4] - Research and development expenses increased to ¥41,023,247.28 in 2025, up from ¥32,643,817.33 in 2024, indicating a focus on innovation[19] Equity - The equity attributable to shareholders increased by 48.93% to ¥902,486,203.35 due to the completion of the initial public offering[8] - The company's equity attributable to shareholders increased to ¥902,486,203.35 from ¥605,965,950.39, representing a significant growth of 48.9%[16] Cash and Cash Equivalents - Cash and cash equivalents rose to ¥133,815,605.65, compared to ¥112,620,868.69 at the end of 2024, indicating an increase of about 18.8%[14] - The total cash and cash equivalents at the end of the period amounted to $133,815,605.65, compared to $111,830,341.13 at the end of the previous period, showing an increase of approximately 19.6%[24] Investment Activities - Net cash outflow from investing activities was -$388,173,960.76, compared to -$332,514,204.00 in the prior period, indicating a decline in investment cash flow[23] - Cash paid for the purchase of fixed assets was $350,838,173.51, slightly down from $353,196,885.67, indicating a decrease of about 0.8%[23] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may affect financial reporting[25]
胜科纳米(688757) - 2025 Q3 - 季度财报